Literature DB >> 10357820

Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes.

J Koipally1, A Renold, J Kim, K Georgopoulos.   

Abstract

Here we show that the lymphoid lineage-determining factors Ikaros and Aiolos can function as strong transcriptional repressors. This function is mediated through two repression domains and is dependent upon the promoter context and cell type. Repression by Ikaros proteins correlates with hypo-acetylation of core histones at promoter sites and is relieved by histone deacetylase inhibitors. Consistent with these findings, Ikaros and its repression domains can interact in vivo and in vitro with the mSin3 family of co-repressors which bind to histone deacetylases. Based on these and our recent findings of associations between Ikaros and Mi-2-HDAC, we propose that Ikaros family members modulate gene expression during lymphocyte development by recruiting distinct histone deacetylase complexes to specific promoters.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357820      PMCID: PMC1171390          DOI: 10.1093/emboj/18.11.3090

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  48 in total

1.  Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

Authors:  J Kim; S Sif; B Jones; A Jackson; J Koipally; E Heller; S Winandy; A Viel; A Sawyer; T Ikeda; R Kingston; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

2.  Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.

Authors:  L Sun; N Heerema; L Crotty; X Wu; C Navara; A Vassilev; M Sensel; G H Reaman; F M Uckun
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.

Authors:  Y Zhang; G LeRoy; H P Seelig; W S Lane; D Reinberg
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

4.  Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex.

Authors:  J K Tong; C A Hassig; G R Schnitzler; R E Kingston; S L Schreiber
Journal:  Nature       Date:  1998-10-29       Impact factor: 49.962

Review 5.  Repression by the Mad(Mxi1)-Sin3 complex.

Authors:  N Schreiber-Agus; R A DePinho
Journal:  Bioessays       Date:  1998-10       Impact factor: 4.345

6.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities.

Authors:  Y Xue; J Wong; G T Moreno; M K Young; J Côté; W Wang
Journal:  Mol Cell       Date:  1998-12       Impact factor: 17.970

7.  Ikaros sets thresholds for T cell activation and regulates chromosome propagation.

Authors:  N Avitahl; S Winandy; C Friedrich; B Jones; Y Ge; K Georgopoulos
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

8.  CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex.

Authors:  J J Hsieh; S Zhou; L Chen; D B Young; S D Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

9.  Down-regulation of human granzyme B expression by glucocorticoids. Dexamethasone inhibits binding to the Ikaros and AP-1 regulatory elements of the granzyme B promoter.

Authors:  A Wargnier; C Lafaurie; S Legros-Maïda; J F Bourge; F Sigaux; M Sasportes; P Paul
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

10.  Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.

Authors:  V Gelmetti; J Zhang; M Fanelli; S Minucci; P G Pelicci; M A Lazar
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more
  121 in total

1.  Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1.

Authors:  S H Yang; E Vickers; A Brehm; T Kouzarides; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

Review 2.  Modifications of the histone N-terminal domains. Evidence for an "epigenetic code"?

Authors:  A Imhof; P B Becker
Journal:  Mol Biotechnol       Date:  2001-01       Impact factor: 2.695

Review 3.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

4.  Sequence analysis of mouse vomeronasal receptor gene clusters reveals common promoter motifs and a history of recent expansion.

Authors:  Robert P Lane; Tyler Cutforth; Richard Axel; Leroy Hood; Barbara J Trask
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

5.  Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation.

Authors:  P Sabbattini; M Lundgren; A Georgiou; C Chow ; G Warnes; N Dillon
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

6.  Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.

Authors:  B S Cobb; S Morales-Alcelay; G Kleiger; K E Brown; A G Fisher; S T Smale
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

7.  Phosphorylation controls Ikaros's ability to negatively regulate the G(1)-S transition.

Authors:  Pablo Gómez-del Arco; Kazushige Maki; Katia Georgopoulos
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

8.  Functional analysis of the Mad1-mSin3A repressor-corepressor interaction reveals determinants of specificity, affinity, and transcriptional response.

Authors:  Shaun M Cowley; Richard S Kang; John V Frangioni; Jason J Yada; Alec M DeGrand; Ishwar Radhakrishnan; Robert N Eisenman
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

Review 9.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18

10.  Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production.

Authors:  Shaun O'Brien; Rajan M Thomas; Gerald B Wertheim; Fuqin Zhang; Hao Shen; Andrew D Wells
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.